123 related articles for article (PubMed ID: 1621012)
1. [The effect of the thyrotropin releasing hormone (TRH) on the motor speech disorder in spinocerebellar degeneration].
Nozaki Y; Hashimoto M; Ohnishi A; Murai Y; Ogata H; Makishima K
J UOEH; 1992 Jun; 14(2):173-83. PubMed ID: 1621012
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
Waragai M; Ogawara K; Takaya Y; Hayashi M
Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
[TBL] [Abstract][Full Text] [Related]
3. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
Touge T; Takeuchi H; Yamada A; Miki H; Nishioka M
Electromyogr Clin Neurophysiol; 1990; 30(3):131-40. PubMed ID: 2112456
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
[TBL] [Abstract][Full Text] [Related]
5. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
[TBL] [Abstract][Full Text] [Related]
7. Oral thyrotropin-releasing hormone treatment in inherited ataxias.
Bonuccelli U; Nuti A; Cei G; Rossi G; Grasso L; Martino E; Muratorio A
Clin Neuropharmacol; 1988 Dec; 11(6):520-8. PubMed ID: 3148366
[TBL] [Abstract][Full Text] [Related]
8. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
[TBL] [Abstract][Full Text] [Related]
9. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
Merola B; Colao A; Di Renzo G; Filla A; Campanella G; Lombardi G
Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
Sobue I; Takayanagi T; Nakanishi T; Tsubaki T; Uono M; Kinoshita M; Igata A; Miyazaki M; Yoshida M; Ando K
J Neurol Sci; 1983 Oct; 61(2):235-48. PubMed ID: 6417282
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Effect of Intensive Speech Therapy on Dysarthria in Patients With Sporadic Spinocerebellar Degeneration.
Sonoda Y; Yoshida N; Kawami K; Kitamura A; Ogawa N; Yamakawa I; Kim H; Sanada M; Imai S; Urushitani M
J Speech Lang Hear Res; 2021 Mar; 64(3):725-733. PubMed ID: 33646821
[TBL] [Abstract][Full Text] [Related]
13. Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
Kimura I; Ohtomo H; Kogure K
Tohoku J Exp Med; 1983 Apr; 139(4):331-7. PubMed ID: 6408760
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and thyrotropin releasing hormone therapy in cerebellar degenerations.
Wang HC; Chiu HC
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Mar; 47(3):161-8. PubMed ID: 1848143
[TBL] [Abstract][Full Text] [Related]
15. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
Ijiro T; Yaguchi A; Yokoyama A; Kiguchi S
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):950-958. PubMed ID: 35637550
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acid therapy for spinocerebellar degeneration: a pilot clinical crossover trial.
Mori N; Adachi Y; Takeshima T; Kashiwaya Y; Okada A; Nakashima K
Intern Med; 1999 May; 38(5):401-6. PubMed ID: 10397076
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of thyrotropin-releasing hormone to neurogenic bladder caused by olivo-ponto-cerebellar atrophy].
Murayama K; Katsumi T
Hinyokika Kiyo; 1985 Mar; 31(3):495-8. PubMed ID: 3927664
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
Yoshida M; Nakanishi T; Komatsu Y
Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
[TBL] [Abstract][Full Text] [Related]
19. [Spinocerebellar degeneration and neuropeptides].
Matsuoka Y; Sakurai N
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1705-8. PubMed ID: 2516527
[No Abstract] [Full Text] [Related]
20. The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications.
Fröhlich E; Wahl R
Front Neuroendocrinol; 2019 Jan; 52():29-43. PubMed ID: 29935915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]